2B Scientific adds business manager to support growth

2B Scientific has appointed Nihad Robinson as business manager.

2B Scientific, a life science products distributor to the UK market, has appointed Nihad Robinson as business manager.

Robinson joins the Upper Heyford, Oxfordshire firm from Cambridge Biosciences where she was responsible for technical sales in the South UK region. She has a degree in microbiology and a PhD in molecular biology, as well as being fluent in Arabic and French.

"I am very proud to be joining 2BScientific and look forward to helping develop the business," she said.

2B Scientific has also expanded its worldwide supplier network by signing deals with Spring Bioscience and BioDynamics.

"We are excited about our new partnerships with US-based Spring Bioscience and Japan's BioDynamics (Funakoshi)," said James Bernard, md of 2B Scientific. "Both of these companies have established businesses and the expertise that will help position the products successfully in the market."

2B Scientific has extended its catalogue portfolio to include Spring Bioscience's cancer markers and tumour suppressors, plus BioDynamic's Hetero-Stagger PCR Cloning Kit, which enables efficient and fast cloning of PCR products without needing any enzymatic procedures.

The firm also offers products from Acris Antibodies (Germany); Cosmo Bio (Japan); Symansis (New Zealand); and ExBio (Czech Republic), among others.

You may also like

Manufacturing

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly redesigns
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
Manufacturing

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From bespoke to scalable: closing the manufacturing gap in advanced therapeutics

Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing

Piramal Pharma Solutions announces partnership with Botanix to support drug substance development

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing

ProtaGene and Merck partner to deliver end-to-end biologics testing

The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle
Subscribe now